Guido Finazzi Selected Research

Guido Finazzi Research Topics

Disease

32	Polycythemia Vera 12/2019 - 01/2003
28	Thrombosis (Thrombus) 01/2022 - 01/2003
18	Essential Thrombocythemia 01/2019 - 05/2003
16	Neoplasms (Cancer) 01/2020 - 08/2007
9	Primary Myelofibrosis (Myelosclerosis) 01/2018 - 01/2003
8	Venous Thrombosis (Deep-Vein Thrombosis) 11/2018 - 08/2007
5	Hemorrhage 11/2018 - 01/2008
5	Polycythemia (Erythrocytosis) 09/2012 - 01/2003
4	Anemia 01/2020 - 01/2003
4	Thrombocytosis (Thrombocythemia) 11/2018 - 09/2006
3	Stroke (Strokes) 11/2018 - 01/2003
3	Venous Thromboembolism 01/2018 - 03/2008
3	Splenomegaly 01/2018 - 02/2011
3	Fibrosis (Cirrhosis) 02/2014 - 05/2009
2	Leukocytosis (Pleocytosis) 11/2018 - 03/2007
2	Pulmonary Embolism 01/2018 - 03/2016
1	Staphylococcal Food Poisoning 12/2020
1	Foodborne Diseases 12/2020
1	Second Primary Neoplasms (Neoplasms, Second) 01/2020
1	Skin Neoplasms (Skin Cancer) 01/2019
1	Transient Ischemic Attack 01/2018
1	Clinical Deterioration 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Ischemic Stroke 01/2018
1	Leukemia 10/2014
1	Thrombophilia 12/2013
1	Thromboembolism 10/2012
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2012
1	Hypertension (High Blood Pressure) 06/2012
1	Philadelphia Chromosome 05/2012
1	Portal Hypertension 02/2011
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 02/2011
1	Inflammation (Inflammations) 02/2011
1	Atrial Fibrillation 10/2009
1	Hyperplasia 05/2009
1	Acute Coronary Syndrome 03/2008
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2008
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 08/2007
1	Disease Progression 03/2007

Drug/Important Bio-Agent (IBA)

17	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2020 - 05/2003
17	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 01/2003
5	ruxolitinibIBA 01/2020 - 02/2017
5	AnticoagulantsIBA 01/2019 - 08/2007
4	Hemoglobins (Hemoglobin)IBA 01/2018 - 07/2012
4	Thrombin FDA Link 03/2016 - 04/2011
4	givinostatIBA 06/2013 - 08/2010
3	Vitamin K FDA Link 01/2018 - 03/2008
3	Janus Kinase 2IBA 10/2014 - 08/2007
3	Reticulin (Reticular Fiber)IBA 02/2014 - 05/2009
3	Histone Deacetylase InhibitorsIBA 06/2013 - 08/2010
2	Thromboxane B2IBA 01/2018 - 09/2006
2	CalreticulinIBA 10/2014 - 10/2014
2	Antiphospholipid AntibodiesIBA 06/2012 - 08/2007
2	Warfarin (Coumadin)FDA LinkGeneric 10/2009 - 08/2007
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	CollagenIBA 01/2022
1	spleen fibrinolytic proteinase (human) (SFP)IBA 12/2020
1	Pipobroman (Vercyte)FDA Link 01/2019
1	Drug CombinationsIBA 01/2019
1	Syntex adjuvant formulationIBA 01/2017
1	apixabanIBA 03/2016
1	Factor Xa (Coagulation Factor Xa)IBA 03/2016
1	RivaroxabanIBA 03/2016
1	Dabigatran FDA Link 03/2016
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2014
1	Protein CIBA 12/2013
1	Adenosine Diphosphate (ADP)IBA 07/2013
1	Purinergic P2 Receptors (ADP Receptor)IBA 07/2013
1	Transcription Factors (Transcription Factor)IBA 08/2012
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2012
1	Everolimus FDA Link 08/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2011
1	AndrogensIBA 02/2011
1	HematinicsIBA 02/2011
1	Immunologic Factors (Immunomodulators)IBA 02/2011
1	PTX3 proteinIBA 02/2011
1	C-Reactive ProteinIBA 02/2011
1	Histone Deacetylases (Histone Deacetylase)IBA 08/2010
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 03/2008
1	AnnexinsIBA 08/2007
1	AntibodiesIBA 08/2007
1	Prothrombin (Factor II)IBA 08/2007
1	APTIBA 08/2007
1	beta 2-Glycoprotein I (Apolipoprotein H)IBA 08/2007
1	Immunoglobulin M (IgM)IBA 08/2007
1	Immunoglobulin G (IgG)IBA 08/2007
1	Anticardiolipin AntibodiesIBA 08/2007
1	Protein SIBA 08/2007
1	beta-ThromboglobulinIBA 09/2006
1	Phosphotransferases (Kinase)IBA 09/2006
1	Platelet Factor 4IBA 09/2006
1	von Willebrand FactorIBA 09/2006

Therapy/Procedure

20	Therapeutics 01/2020 - 01/2003
2	Renal Dialysis (Hemodialysis) 10/2012 - 10/2009
2	Drug Therapy (Chemotherapy) 08/2007 - 01/2003
1	Liver Transplantation 01/2018
1	Stem Cell Transplantation 01/2018
1	Splenectomy 02/2011
1	Contraindications 10/2009
1	Operative Surgical Procedures 01/2008